Malaria Drug Accelerator (MalDA)
The Malaria Drug Accelerator – MalDA (Formerly MDTIP) is a collaboration funded by the Bill and Melinda Gates foundation to use chemogenomic methods to identify the drug target and mechanism of action for the fifty most prominent compounds in the Malaria Box.
MalDA Members
Bill and Melinda Gates Foundation
Omar Vandal
David Fidock Lab at Columbia University
Manu Vanaerschot
Pennsylvania State University
Manuel Llinas
Dyann Wirth Lab at Harvard University
Pamela Magistrado
Amanda Lukens
Daniel Goldberg Lab at Washington University in St. Lous
Eva Istvan
Elizabeth Winzeler Lab at UC San Diego
Purva Gupta
Sabine Ottilie
GlaxoSmithKline
Francisco Javier Gamo-Benito
Wellcome Trust Sanger Institute
Marcus Lee
The Medicines For Malaria Venture
Paul Willis
Message us for inquiries regarding the MalDA project
